The product has been added to the cart.
By using our website, you agree to our use of cookies. find out more.
-
Products
Pharmacology
Type
- News
- Custom services
- Ordering
- About Us
- Technical support
- Resources
-
Products
Pharmacology
Type
- News
- Custom services
- Ordering
- About Us
- Technical support
- Resources
CD36 peptide
Cat. No. PP-510
Structure:
Other Names:
Activity:
CD36 peptide is derived from CD36 (cluster of differentiation 36), also known as platelet glycoprotein 4 or fatty acid translocase (FAT), a plasma membrane protein of wide cellular distribution which functions as a receptor for thrombospondin (TSP). CD36 peptide blocks binding of CD36 to TSP and partially inhibits collagen induced platelet aggregation, but does not itself bind to TSP. TSP1 plays a pivotal role in obesity related inflammation and insulin resistance by modulating macrophage accumulation and activation in adipose tissue, and CD36 peptide, functioning as a TSP1 antagonist, effectively inhibits this activation. In an obese mouse model, CD36 peptide treatment does not affect obesity or weight gain but attenuates systemic inflammation and reduces proinflammatory cytokine production. CD36 peptide treatment improves glucose tolerance and insulin sensitivity and mitigates obesity related fatty liver disease and kidney damage.
Leung et al (1992) CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction. J Biol Chem. 267(25) 18244 PMID: 1381367
Li et al (2013) Thrombospondin 1 activates the macrophage Toll-like receptor 4 pathway. Cell Mol Immunol. 10(6) 506 PMID: 23954950
Zhou et al (2023) Thrombospondin1 antagonist peptide treatment attenuates obesity-associated chronic inflammation and metabolic disorders in a diet-induced obese mouse model. Sci Rep. 13(1) 20193 PMID: 37980376
Related areas
All peptides >
All protein-protein interaction modulators >
All immunology research categories >
All diabetes research categories >
Technical Data
| Structure | H-Tyr-Arg-Val-Arg-Phe-Leu-Ala-Lys-Glu-Asn-Val-Thr-Gln-Asp-Ala-Glu-Asp-Asn-OH |
| Molecular Weight | 2167.07 |
| Formula | C93H146N28O32 |
| Sequence | YRVRFLAKENVTQDAEDN |
| Modifications | None |
Solubility and Storage
| Solubility | Soluble in saline |
| Appearance | Freeze dried solid |
| Storage | Store dry, frozen and in the dark |
Batch Specific Data
| Purity | >95% by hplc |
Contact Information
To place an order, or for customer services, order processing or technical support please contact us on:
UK, Europe and RoW
Tel: (+44) 01392 422205
Fax: (+44) 01392 279510
info@iscabiochemicals.com
USA and Canada
Tel: 610-994-1134
Toll Free: 855-FOCUS21 (855-362-8721)
Fax: 610-465-9100
France
CliniSciences
Tel : +33 9 77 40 09 09
Fax : +33 9 77 40 10 11
Orders and customer support : info@clinisciences.com
Germany, Switzerland, Austria
BIOZOL Diagnostics
Tel: +49 (089) 3799 666-6
Fax: +49 (089) 3799 666-99
Orders, Technical and Customer support: info@biozol.de
Italy
Labospace
Tel: +39 02 35980841
Fax +39 02 359808004
Orders: info@labospace.com
Spain and Portugal
Abyntek Biopharma
Tel: +34 94 404 80 80
Fax: +34 94 404 80 81
Orders: info@abyntek.com
BIOHUB INTERNATIONAL
上海起发实验试剂有限公司
Tel: +86-15921799099
Tel: +86-021-50724187
Fax: +86-021-50724961
Orders: sale3@78bio.com
India
BTL Biotechno Labs Pvt Ltd
Tel: +91-8860924629
07291852429
Orders, Technical and Customer support: info@biotechnolabs.com
Japan
Namiki Shoji Co.
Tel:+81-050-5527-9850
Fax:+81-3-3352-2196
email: globalbusiness1@namiki-s.co.jp
Recent citations
A new publication from the University of Ljubljana uses MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2, the FRET substrate for the severe acute respiratory syndrome coronavirus main protease (SARS-CoV Mpro), to determine the inhibitory potential of plant polyphenols
Learn moreContact us
Isca Biochemicals
26 Hanover Road
Exeter
EX1 2TL
(+44) 01392 422205
info@iscabiochemicals.com